EDGAR Filing Documents for 0001193125-09-162193

Form 8-K - Current report:

SEC Accession No. 0001193125-09-162193

Filing Date

2009-08-03

Accepted

2009-08-03 16:04:26

Documents

Period of Report

2009-07-29

Items

Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	21361
2	FORM OF 6 MONTH WARRANT	dex41.htm	EX-4.1	75917
3	FORM OF 4 YEAR WARRANT	dex42.htm	EX-4.2	75239
4	SECURITIES PURCHASE AGREEMENT	dex101.htm	EX-10.1	230458
5	PRESS RELEASE DATED JULY 30, 2009	dex991.htm	EX-99.1	49293
6	PRESS RELEASE DATED JULY 31, 2009	dex992.htm	EX-99.2	7171
	Complete submission text file	0001193125-09-162193.txt		461059

Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010

Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200

ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)